Squarepoint
EXAS

Squarepoint’s Exact Sciences EXAS Stock Holding History

Squarepoint’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,100
Closed -$3.97M – 4456
2025
Q4 		$3.97M Buy
39,100
+19,300
+97% +$1.55M ﹤0.01% 1593
2025
Q3 		$1.08M Buy
19,800
+1,800
+10% +$89.9K ﹤0.01% 2625
2025
Q2 		$957K Sell
18,000
-12,300
-41% -$625K ﹤0.01% 2699
2025
Q1 		$1.31M Sell
30,300
-41,000
-58% -$2.08M ﹤0.01% 2431
2024
Q4 		$4.01M Buy
71,300
+52,400
+277% +$3.26M ﹤0.01% 1821
2024
Q3 		$1.29M Buy
18,900
+13,200
+232% +$745K ﹤0.01% 2409
2024
Q2 		$241K Sell
5,700
-251,800
-98% -$13.9M ﹤0.01% 3555
2024
Q1 		$17.8M Buy
257,500
+249,000
+2,929% +$15.8M 0.03% 669
2023
Q4 		$629K Sell
8,500
-29,900
-78% -$1.96M ﹤0.01% 2846
2023
Q3 		$2.62M Sell
38,400
-4,600
-11% -$390K 0.01% 1610
2023
Q2 		$4.04M Buy
43,000
+6,600
+18% +$515K 0.01% 1199
2023
Q1 		$2.47M Buy
+36,400
New +$2.34M 0.01% 1302
2021
Q4 		– Sell
-2,100
Closed -$200K – 3261
2021
Q3 		$200K Hold
2,100
– – ﹤0.01% 2488
2021
Q2 		$261K Hold
2,100
– – ﹤0.01% 2625
2021
Q1 		$277K Hold
2,100
– – ﹤0.01% 2466
2020
Q4 		$278K Buy
+2,100
New +$254K ﹤0.01% 2263

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Squarepoint's EXAS Position: Q1 2026 in Review

Squarepoint sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 793,505 shares — an estimated $80.6M sold.

Squarepoint first reported a position in EXAS in Q4 2015 and held it in 33 quarters. The position peaked at $80.6M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Squarepoint reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 793,505 Exact Sciences shares in Q1 2026, an estimated $80.6M.
  • Squarepoint first reported a position in Exact Sciences in Q4 2015 and held it in 33 quarters.
  • Squarepoint's Exact Sciences position peaked at $80.6M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.